Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026)
Ufp Technologies' (UFPT) quarterly EBITDA Margin came in at 16.15% in Q2 2026, up 6.0% on a YoY basis from 15.24% in Q2 2025, and up 6.59% quarter-over-quarter from 15.15% in Q1 2026.
Analysis
Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported EBITDA Margin for 17 consecutive years, with 16.15% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 6.0% year-over-year to 16.15%; the trailing twelve-month figure through Jun 2026 stood at 15.25% (down 80.0% YoY), and the FY2025 full-year result was 15.32%, down 72.0% from the prior year.
- EBITDA Margin climbed to 16.15% in Q2 2026 per UFPT's latest filing, from 15.15% in the prior quarter.
- Across five years, EBITDA Margin topped out at 26.78% in Q3 2022 and bottomed at 8.93% in Q1 2022.
- Historically, EBITDA Margin has averaged 15.26% across 5 years, with a median of 15.16% in 2026.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 1677 bps in 2022, then plunged 1185 bps in 2023.
- Over 5 years, EBITDA Margin stood at 11.92% in 2022, then climbed by 5 bps to 12.55% in 2023, then rose by 23 bps to 15.45% in 2024, then slipped by 7 bps to 14.44% in 2025, then increased by 12 bps to 16.15% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 16.15%, 15.15%, and 14.44% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 16.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.15% |
| Mar 31, 2026 | 15.15% |
| Dec 31, 2025 | 14.44% |
| Sep 30, 2025 | 15.13% |
| Jun 30, 2025 | 16.09% |
| Mar 31, 2025 | 15.61% |
| Dec 31, 2024 | 15.45% |
| Sep 30, 2024 | 17.06% |
| Jun 30, 2024 | 16.29% |
| Mar 31, 2024 | 15.16% |
| Dec 31, 2023 | 12.55% |
| Sep 30, 2023 | 14.93% |
| Jun 30, 2023 | 17.04% |
| Mar 31, 2023 | 13.14% |
| Dec 31, 2022 | 11.92% |
| Sep 30, 2022 | 26.78% |
| Jun 30, 2022 | 12.93% |
| Mar 31, 2022 | 8.93% |
| Dec 31, 2021 | 8.22% |
| Sep 30, 2021 | 10.01% |